Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Placebo-Weeks'

Placebo-Weeks published presentations and documents on DocSlides.

Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in
Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in
by pamella-moone
Hyperlipidemic. Subjects: A 52 Week Phase 3 Dou...
Treatment of Cerebellar Motor Dysfunction
Treatment of Cerebellar Motor Dysfunction
by lois-ondreau
Theresa A. . Zesiewicz. , MD FAAN. Director, USF ...
FOURIER F urther cardiovascular
FOURIER F urther cardiovascular
by trish-goza
OU. tcomes. . R. esearch with PCSK9 . I. nhibiti...
STAT 101 Dr. Kari Lock Morgan
STAT 101 Dr. Kari Lock Morgan
by aaron
9/4/12. Collecting Data: Experiments. SECTION 1.3...
LABA LAMA EN EPOC QUE GANAMOS CON LA TERAPIA
LABA LAMA EN EPOC QUE GANAMOS CON LA TERAPIA
by liane-varnes
BRONCODILATORA DUAL. Dr. Mark Cohen . Todd. Neum...
THE ART AND SCIENCE OF HEALING:
THE ART AND SCIENCE OF HEALING:
by stefany-barnette
CARDWELL C. NUCKOLS, PhD. CNUCKOLS@ELITECORP1.COM...
Heart Failure Guidelines
Heart Failure Guidelines
by giovanna-bartolotta
Patrice M. Schneider RN BSN. Heart Failure Coordi...
The Effect of High-Dose Atorvastatin on Neural Activity and Cognitive Function
The Effect of High-Dose Atorvastatin on Neural Activity and Cognitive Function
by myesha-ticknor
Beth A. Taylor, Ph.D.. Director, Exercise Physiol...
Stop Smoking Interventions
Stop Smoking Interventions
by test
Smokefree Nurses. Auckland . March 19th 2015. Mar...
Peter Fisher FRCP, FFHom
Peter Fisher FRCP, FFHom
by olivia-moreira
Director of Research. Royal London Hospital for I...
Complementary and Alternative Medicine (CAM)
Complementary and Alternative Medicine (CAM)
by min-jolicoeur
Learning objectives. What is ‘conventional’ m...
New Drugs The Good, The Bad,
New Drugs The Good, The Bad,
by jane-oiler
and the Worthless. Bill Origer MD. OAFP 2015. Dis...
Do antidepressants really work?
Do antidepressants really work?
by jane-oiler
Group 4: Chan Yong Ming, Timothy . Peh. , Bernett...
Cholesterol Treatment Trialists’ (CTT) Collaboration
Cholesterol Treatment Trialists’ (CTT) Collaboration
by briana-ranney
Slide deck. CTT Collaboration: Background*. Histo...
Reduction in Ischemic Events with
Reduction in Ischemic Events with
by natalia-silvester
Ticagrelor. in Diabetic Patients from the PEGASU...
A n update in the management of
A n update in the management of
by conchita-marotz
. Hypertensive Emergency . In Patients . with Ac...
Michael S. Saag , MD Eric S.
Michael S. Saag , MD Eric S.
by pamella-moone
Daar. , MD. Antiretroviral Therapy:. A Case-Based...
The Fight Against Obesity
The Fight Against Obesity
by marina-yarberry
as a Disease: Tackling the . Core of the Conditio...
SUPERFIX Lameness And Performance
SUPERFIX Lameness And Performance
by lois-ondreau
Introduction and Aim. A standardised . product, m...
Aperçu des essais cliniques
Aperçu des essais cliniques
by jane-oiler
2. Syndrome du côlon irritable avec constipation...
How to Design an Experiment
How to Design an Experiment
by natalia-silvester
Module . 4. Experimental . psychology . guided-in...
The EINSTEIN EXT Study 'Xarelto' for
The EINSTEIN EXT Study 'Xarelto' for
by tatiana-dople
the . Long-Term Prevention of Recurrent Venous Th...
Herbs and Supplements Reetu Grewal, MD
Herbs and Supplements Reetu Grewal, MD
by tatyana-admore
Community Health & Family Medicine. UF Health...
Antiangiogenic Agents in Advanced NSCLC
Antiangiogenic Agents in Advanced NSCLC
by ellena-manuel
Jared Weiss, MD . Assistant . Professor of Medici...
Novel Biologic Therapies for
Novel Biologic Therapies for
by olivia-moreira
Second-Line Gastric Cancer. Charles S. Fuchs, MD....
Where we are with targeted
Where we are with targeted
by stefany-barnette
therapies . for . cholangiocarcinoma. Professor J...
My Experiences as an FDA Statistician
My Experiences as an FDA Statistician
by aaron
Yeh-Fong Chen, Ph.D. . FDA/CDER/OB/DB3. CBA 2016-...
Designing Experiments
Designing Experiments
by myesha-ticknor
Back to my rabbit food:. I. . plan to test my ne...
Migraine Overview
Migraine Overview
by ellena-manuel
David Watson, MD. Director, WVU Headache Center. ...
Why Do We Treat Obesity?
Why Do We Treat Obesity?
by myesha-ticknor
Metabolic Complications. 2. Diabetes Risk. Metabo...
Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
by yoshiko-marsland
(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....
Randomized Controlled Trials of Methotrexate & Mycophen
Randomized Controlled Trials of Methotrexate & Mycophen
by liane-varnes
Richard J. Barohn, MD. Chair, Department of Neuro...
Psychiatry Meeting
Psychiatry Meeting
by myesha-ticknor
24. th. November 2016. Andrew Gallagher. Consult...
Prediabetes Management
Prediabetes Management
by giovanna-bartolotta
1. AACE Prediabetes Consensus Statement: Summary....
Experiments: Part 2
Experiments: Part 2
by liane-varnes
Overview. This section mainly reviews some of the...
The Viscosupplementation Debate
The Viscosupplementation Debate
by phoebe-click
Nilesh Shah, MD, CAQSM. Disclosures. None. 2. Dis...
Prevention of Postoperative Crohn’s disease
Prevention of Postoperative Crohn’s disease
by jane-oiler
Miguel Regueiro, M.D.. Professor of Medicine. Ass...
Single factor design
Single factor design
by cheryl-pisano
Week 5. SRM I Special Session. Thu 8 pm, . TR202,...
305 Study
305 Study
by test
Randomised, Double Blind, Placebo Controlled Phas...
Heart Failure Management
Heart Failure Management
by faustina-dinatale
(2013 Updated Guidelines). Blake Wachter, MD, PhD...